Celularity, Inc. (CELU) vs Sangamo Therapeutics, Inc. (SGMOQ)
Celularity, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Celularity, Inc. and Sangamo Therapeutics, Inc. are of similar size ($41.9M and $38.2M). Sangamo Therapeutics, Inc. grew revenue faster over the last twelve months: −45.8% against −51.0%. Celularity, Inc. has the higher net margin (−345.8% vs −356.9%) and the lower return on invested capital (−1,070.9% vs 0.00%). Across the 17 metrics below, Celularity, Inc. leads on 10 and Sangamo Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | CELU | SGMOQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 24.39% | 100.00% | 65.16% |
| Operating margin | (230.92%) | (357.55%) | 0.00% |
| Net margin | (345.76%) | (356.89%) | 0.00% |
| Free cash flow margin | (49.92%) | (261.76%) | 0.00% |
| Return on equity | 628.23% | 1,755.72% | (57.72%) |
| Return on assets | (76.50%) | (168.79%) | (49.22%) |
| Return on invested capital | (1,070.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack